middle.news
How Neurizon’s NUZ-001 Could Transform ALS Treatment with New Liquid Formulation
9:23am on Wednesday 30th of July, 2025 AEST
•
Biotechnology
Read Story
How Neurizon’s NUZ-001 Could Transform ALS Treatment with New Liquid Formulation
9:23am on Wednesday 30th of July, 2025 AEST
Key Points
Development of patient-friendly liquid formulation of NUZ-001 for ALS
Completion of 12-month Open Label Extension study showing promising survival benefits
Submission of Clinical Hold Complete Response to FDA aiming to lift clinical hold
Exclusive global license agreement signed with Elanco Animal Health for monepantel
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NUZ
OPEN ARTICLE